Skip to content

Safety and Efficacy of Infrared Diode Laser on Improvement of Scar and Prevention of Recurrence of Excised Keloid

Effect of Infra-red Diode Laser on Improvement of Surgical Scar and on the Prevention of Excised Keloids Recurrence-Pilot Study

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01158196
Enrollment
60
Registered
2010-07-08
Start date
2010-06-30
Completion date
2013-06-30
Last updated
2010-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keloid, Surgical Scar

Keywords

laser, keloid, scar

Brief summary

A pilot study will be conducted on 2 type of subjects, one with plastic surgery scar with a randomization of laser treated portions, and other with keloid excision scar with a complete laser treatment. The aim is to evaluate the infra-red diode laser influence on keloid recurrence and scar prevention. The keloid recurrence rate will be evaluated at each visit, and the scar prevention in plastic surgery will be evaluated comparing laser treated portion and non-treated portion.

Interventions

DEVICEinfra-red diode laser

laser treatment of scar after keloid excision laser treatment of surgery scar

Sponsors

Ekkyo
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 18 years and older * Skin type from I to VI (Fitzpatrick classification scale) * Scar longer than 4cm for plastic surgery's patients OR scar longer than 2cm for keloid patients

Exclusion criteria

* Malignant tumor pathology * Infectious or viral skin disease * Immunosuppressive pathology and/or immunosuppressive treatment, * Long-term corticosteroid treatment * Pregnant woman

Design outcomes

Primary

MeasureTime frame
treatment tolerability assessed by natures, intensity and incidences of the side effects, with a special oversight of skin burn lesion10 days after surgery or excision

Secondary

MeasureTime frameDescription
improvement of scarring for plastic surgery group12 months after surgery* Vancouver Scar Scale score * Comparative scar assessment scale * Observer assessment score (POSAS)
keloid recurrence, an intralesional corticotherapy will be set up as soon as there is a recurrence.12 months after excision* Lesion size * Vancouver scar scale * Observer scar scale (POSAS)
quality of life assessment for keloid group12 months after excision* VQ-dermato * satisfaction questionnaire
Socio and medical economic evaluation for keloid group12 months after excision

Countries

France

Contacts

Primary ContactGuy MAGALON, MD PhD
guy.magalon@ap-hm.fr+33 (0)4 91 38 35 52

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026